Lexiscan Lawsuits are now being accepted on behalf of individuals who suffered heart attacks or died after being administered the drug. Since it was approved as a nuclear stress agent used to identify coronary artery disease (CAD) in April 2008, Lexiscan has been linked to at least 26 heart attacks and 29 deaths. As a result of these problems, the U.S. Food & Drug Administration (FDA) has required updated warnings on labels of Lexiscan describing the risk of heart attacks and death associated with the medication.
Free Lexiscan Lawsuit Evaluation: If you or a loved one was injured by Lexiscan, you should contact our law firm immediately. You may be entitled to compensation by filing a lawsuit and we can help.
What is Lexiscan?
Astellas Pharma’s Lexiscan (generic: regadenoson) is an FDA-approved prescription drug designed to identify coronary artery disease (CAD) by dilating the arteries of the heart and increasing blood flow to help find obstructions in the arteries. Lexiscan is administered intravenously in preparation for a myocardial perfusion imaging (MPI) test. This procedure utilizes a specialized camera that takes pictures of the heart, giving the doctor detailed information about blood flow into the patient’s heart. Lexiscan was approved for sale on the U.S. market on June 24, 2008.
Why Are Lexiscan Lawsuits Being Filed?
Due to the fact that Lexiscan causes blood to flow to the unblocked arteries, the drug can reduce blood flow in the obstructed artery. In some cases, this reduced blood flow can lead to a heart attack or even death. Signs and symptoms of a Lexiscan heart attack may include:
- Discomfort, pressure, heaviness, or pain in the chest, arm, or below the breastbone
- Discomfort radiating to the back, jaw, throat, or arm
- Fullness, indigestion, or choking feeling
- Sweating, nausea, vomiting, or dizziness
- Extreme weakness, anxiety, or shortness of breath
- Rapid or irregular heartbeats
FDA Safety Warning on Lexiscan
On November 20, 2013, the U.S. Food & Drug Administration issued a warning about the risk of heart attack and death linked to Lexiscan. A review of FDA adverse event data found at least 26 heart attacks and 29 deaths in Lexiscan users between June 24, 2008, and April 10, 2013. The FDA did not always specify when the complications occurred, but when the timing was specified, they tended to occur within six hours of a stress test.
As a result of these events, the FDA has required Astellas to update Lexiscan warning labels with the following verbiage:
“Myocardial Ischemia: Fatal cardiac events have occurred. Avoid use in patients with symptoms or signs of acute myocardial ischemia, for example unstable angina or cardiovascular instability, who may be at greater risk. Cardiac resuscitation equipment and trained staff should be available before administration.”
Lexiscan Side Effects
In addition to being linked to potentially fatal cardiac events, Lexiscan has also been known to cause the following moderate side effects:
- arm, back, or jaw pain
- chest pain or discomfort
- difficult or labored breathing
- fast or irregular heartbeat
- shortness of breath
- tightness in the chest
Do I Have a Lexiscan Lawsuit?
The Product Liability & Defective Drug Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Adenoscan lawsuits. We are handling individual litigation nationwide and currently accepting new Lexiscan heart attack and death lawsuits in all 50 states.
Free Lexiscan Lawsuit Evaluation: Again, if you or a loved one was injured by Lexiscan, you should contact our law firm immediately. You may be entitled to compensation by filing a lawsuit and we can help.